Skip to main navigation

Overview
News & Events
- News Releases
- Events
Financials
- Quarterly Results
- SEC Filings
Stock
Governance
Resources

Event Details

News & Events

News Releases
Events

Q3 2026 Illumina, Inc. Earnings Conference Call

October 29, 2026 | 1:30 PM PDT

Add to Outlook

Add to Google Calendar

Investor Contact

draftsir@illumina.com

phone_iphone858.291.6421

Subscribe to our Email Alerts

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina Korea

14F iM Investment & Securities building
66 Yeoidaero Yeoungdeungpo-gu
Seoul Korea 07325

02-740-5300 (tel)
02-786-8368 (fax)
customercare@illumina.com

판매 약관 | Tax Reg: 105-87-87282 | Retailer Reg: 2019-서울영등포-2018 | Host: https://www.illumina.com | Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.

|

Site Map

Search Investors

Search this site